Status:
COMPLETED
Effect of Vitamin K2 Over Osteocalcin, Leptin, Cytokines, and Cardiovascular Risk in Young Adults With Overweight and Obesity
Lead Sponsor:
University of Guadalajara
Conditions:
Overweight and Obesity
Cardiometabolic Risk Factors
Eligibility:
All Genders
18-35 years
Phase:
NA
Brief Summary
The goal of this clinical trial is to compare de effect of vitamin K2 in young adults with overweight or obesity. The main questions to answer are: What is the effect of Vitamin K2 supplementation on...
Detailed Description
Study Overview To meet the objectives of the project, two groups will be compared, one that will be supplemented with vitamin K and another of patients who will receive corn starch as a placebo. Patie...
Eligibility Criteria
Inclusion
- Body Mass Index greater than 25 kg/m2 and less than 40 kg/m2
- That they agree to participate in the study voluntarily and informed and sign the informed consent
Exclusion
- People with self-reported diagnosis of chronic kidney, gastrointestinal or systemic disease
- Use of bile acid sequestrants drugs, insulin, glucocorticoids, contraceptives, bisphosphonates, thiazides, levetiracetam, thiazolidinediones, anticoagulants or estrogenic drugs and vitamin D, vitamin K, vitamin A, vitamin E, omegas or calcium supplements
- Patients who are on a hypocaloric or low-fat diet
- Self-reported pregnancy
Key Trial Info
Start Date :
September 1 2023
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 31 2023
Estimated Enrollment :
51 Patients enrolled
Trial Details
Trial ID
NCT05995522
Start Date
September 1 2023
End Date
December 31 2023
Last Update
May 8 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Guadalajara
Guadalajara, Jalisco, Mexico, 44340